Post-ASCO & EHA 2024 Highlights
Webinar series by VJHemOnc featuring presentations & discussions on key abstracts in hematological malignancies presented at the ASCO & EHA 2024 meetings.
Webinar series by VJHemOnc featuring presentations & discussions on key abstracts in hematological malignancies presented at the ASCO & EHA 2024 meetings.
Isatuximab plus VRd produced a statistically significant improvement in PFS vs VRd in newly diagnosed, transplant-ineligible multiple myeloma.
Annals of Surgical Oncology – Retroperitoneal sarcomas are a complex and heterogenous group of tumors. An approach to these tumors should be guided by a…
An abstract is unavailable.
Zyed Nabeel Zafar, MD, MPH, explores the nuances of postoperative considerations in pancreatic cancer treatment.
An international, multicenter, first-in-human, phase 1/2 study of PFL-002/VERT-002 plans to enroll patients with NSCLC with MET alterations and expects to begin patient enrollment by…
Brittany L. Bychkovsky, MD, MSc, and Lydia Pace, MD, MPH, explain approaches to breast cancer screening and considerations with the final USPSTF screening recommendations.
Jeffrey M. Farma, MD, FACS, has been appointed chair of surgery at Fox Chase Cancer Center.Farma will oversee all departmental educational activities — including professional,…
October 18-19, 2024
During a Case-Based Roundtable® event, Sumanta Kumar Pal, MD, discussed regimens for recurrent metastatic clear cell renal cell carcinoma including lenvatinib plus everolimus, belzutifan, and…